BioLife Solutions Inc (BLFS)
Who owns BioLife Solutions Inc (BLFS)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 87.4% of the shares are freely tradable; institutional investors hold 104.5%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| T. Rowe Price Investment Management,Inc. | 13.32 | 6,506,346 | +19.2 | 03/31/2026 |
| BlackRock Inc | 12.49 | 6,101,765 | +3.2 | 03/31/2026 |
| Casdin Capital, LLC | 12.19 | 5,957,165 | +0.0 | 03/31/2026 |
| Vanguard Group Inc | 6.32 | 3,087,386 | +4.0 | 12/31/2025 |
| Amvescap Plc. | 4.81 | 2,348,532 | -40.3 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.93 | 1,917,708 | +0.0 | 03/31/2026 |
| State Street Corp | 3.23 | 1,577,076 | +4.7 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| T. Rowe Price US Small-Cap Core Equity | 5.24 | 2,562,102 | +17.5 | 03/31/2026 |
| T. Rowe Price Small-Cap Stock | 5.24 | 2,560,279 | -0.1 | 04/30/2026 |
| iShares Core S&P Small-Cap ETF | 4.84 | 2,365,635 | +0.0 | 05/29/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 17. Jul 2026 | Werner Sean | Chief Technology Officer | Other | 275 | 29.15 | 8,016 |
| 7. Jul 2026 | Wichterman Troy | Chief Financial Officer | Other | 844 | 27.79 | 23,455 |
| 7. Jul 2026 | Mathew Aby J. | EVP & Chief Scientific Officer | Other | 516 | 27.79 | 14,340 |
| 7. Jul 2026 | Berard Todd | Chief Marketing Officer | Other | 293 | 27.79 | 8,142 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.